{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:21:09Z","timestamp":1794367269106,"version":"4.9.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41569-021-00570-z","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T09:03:16Z","timestamp":1624611796000},"page":"853-864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":745,"title":["Global epidemiology of valvular heart disease"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-4666","authenticated-orcid":false,"given":"Sean","family":"Coffey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Roberts-Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2112-3918","authenticated-orcid":false,"given":"Alex","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0910-5450","authenticated-orcid":false,"given":"Maurice","family":"Enriquez-Sarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Z\u00fchlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6031-2124","authenticated-orcid":false,"given":"Bernard D.","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"570_CR1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/0002-8703(93)91036-E","volume":"125","author":"SN Vaslef","year":"1993","unstructured":"Vaslef, S. N. & Roberts, W. C. Early descriptions of aortic valve stenosis. Am. Heart J. 125, 1465\u20131474 (1993).","journal-title":"Am. Heart J."},{"key":"570_CR2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/eurheartj\/ehz948","volume":"41","author":"RK Binder","year":"2020","unstructured":"Binder, R. K., Dweck, M. & Prendergast, B. The year in cardiology: valvular heart disease. Eur. Heart J. 41, 912\u2013920 (2020).","journal-title":"Eur. Heart J."},{"key":"570_CR3","unstructured":"Institute for Health Metrics and Evaluation. GBD Results Tool. IHME http:\/\/ghdx.healthdata.org\/gbd-results-tool (2021)."},{"key":"570_CR4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/heartjnl-2016-310718","volume":"103","author":"S Coffey","year":"2017","unstructured":"Coffey, S. et al. Clinical information has low sensitivity for postmortem diagnosis of heart valve disease. Heart 103, 1031\u20131035 (2017).","journal-title":"Heart"},{"key":"570_CR5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2018-313082","volume":"104","author":"SKM Gardezi","year":"2018","unstructured":"Gardezi, S. K. M. et al. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients. Heart 104, 1832\u20131835 (2018).","journal-title":"Heart"},{"key":"570_CR6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","volume":"141","author":"S Yadgir","year":"2020","unstructured":"Yadgir, S. et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017. Circulation 141, 1670\u20131680 (2020).","journal-title":"Circulation"},{"key":"570_CR7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","volume":"83","author":"JP Singh","year":"1999","unstructured":"Singh, J. P. et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am. J. Cardiol. 83, 897\u2013902 (1999).","journal-title":"Am. J. Cardiol."},{"key":"570_CR8","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","volume":"37","author":"JL D\u2019Arcy","year":"2016","unstructured":"D\u2019Arcy, J. L. et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur. Heart J. 37, 3515\u20133522 (2016).","journal-title":"Eur. Heart J."},{"issue":"Suppl. 6","key":"570_CR9","first-page":"A102","volume":"105","author":"S Myerson","year":"2019","unstructured":"Myerson, S. et al. Survival with valvular heart disease (OxValve-Survive) [abstract 124]. Heart 105 105 (Suppl. 6), A102 (2019).","journal-title":"Heart"},{"key":"570_CR10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005\u20131011 (2006).","journal-title":"Lancet"},{"key":"570_CR11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/heartjnl-2019-316238","volume":"106","author":"O Chehab","year":"2020","unstructured":"Chehab, O. et al. Secondary mitral regurgitation: pathophysiology, proportionality and prognosis. Heart 106, 716\u2013723 (2020).","journal-title":"Heart"},{"key":"570_CR12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehu449","volume":"36","author":"L Z\u00fchlke","year":"2015","unstructured":"Z\u00fchlke, L. et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur. Heart J. 36, 1115\u20131122 (2015).","journal-title":"Eur. Heart J."},{"key":"570_CR13","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J. Am. Coll. Cardiol. 76, 2982\u20133021 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCULATIONAHA.116.024769","volume":"134","author":"L Z\u00fchlke","year":"2016","unstructured":"Z\u00fchlke, L. et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation 134, 1456\u20131466 (2016).","journal-title":"Circulation"},{"key":"570_CR15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004515","volume":"6","author":"K Roberts","year":"2017","unstructured":"Roberts, K. et al. Echocardiographic screening for rheumatic heart disease in indigenous Australian children: a cost-utility analysis. J. Am. Heart Assoc. 6, e004515 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"570_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5694\/mja2.50682","volume":"213","author":"JR Francis","year":"2020","unstructured":"Francis, J. R. et al. Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening. Med. J. Aust. 213, 118\u2013123 (2020).","journal-title":"Med. J. Aust."},{"key":"570_CR17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1440-1754.2012.02446.x","volume":"48","author":"RJ Milne","year":"2012","unstructured":"Milne, R. J. et al. Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand. J. Paediatr. Child. Health 48, 692\u2013697 (2012).","journal-title":"J. Paediatr. Child. Health"},{"key":"570_CR18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","volume":"377","author":"DA Watkins","year":"2017","unstructured":"Watkins, D. A. et al. Global, regional, and national burden of rheumatic heart disease, 1990\u20132015. N. Engl. J. Med. 377, 713\u2013722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"570_CR19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12872-017-0725-9","volume":"17","author":"RM de Aquino Xavier","year":"2017","unstructured":"de Aquino Xavier, R. M. et al. Medium-term outcomes of 78,808 patients after heart valve surgery in a middle-income country: a nationwide population-based study. BMC Cardiovasc. Disord. 17, 302 (2017).","journal-title":"BMC Cardiovasc. Disord."},{"key":"570_CR20","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1136\/heartjnl-2011-300792","volume":"97","author":"A Saxena","year":"2011","unstructured":"Saxena, A. et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart 97, 2018\u20132022 (2011).","journal-title":"Heart"},{"key":"570_CR21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/hrt.2004.042762","volume":"91","author":"ZM Meira","year":"2005","unstructured":"Meira, Z. M., Goulart, E. M., Colosimo, E. A. & Mota, C. C. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 91, 1019\u20131022 (2005).","journal-title":"Heart"},{"key":"570_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5694\/mja15.00139","volume":"203","author":"KV Roberts","year":"2015","unstructured":"Roberts, K. V. et al. Rheumatic heart disease in indigenous children in northern Australia: differences in prevalence and the challenges of screening. Med. J. Aust. 203, 221 (2015).","journal-title":"Med. J. Aust."},{"key":"570_CR23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.hlc.2010.02.021","volume":"19","author":"N Wilson","year":"2010","unstructured":"Wilson, N. Rheumatic heart disease in indigenous populations \u2013 New Zealand experience. Heart Lung Circ. 19, 282\u2013288 (2010).","journal-title":"Heart Lung Circ."},{"key":"570_CR24","unstructured":"New Zealand Ministry of Health. Reducing rheumatic fever. New Zealand Government https:\/\/www.health.govt.nz\/our-work\/diseases-and-conditions\/rheumatic-fever\/reducing-rheumatic-fever (2021)."},{"key":"570_CR25","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"S Coffey","year":"2014","unstructured":"Coffey, S., Cox, B. & Williams, M. J. A. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 63, 2852\u20132861 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR26","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2019.08.004","volume":"74","author":"G Strange","year":"2019","unstructured":"Strange, G. et al. Poor long-term survival in patients with moderate aortic stenosis. J. Am. Coll. Cardiol. 74, 1851\u20131863 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR27","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","volume":"385","author":"SR Kapadia","year":"2015","unstructured":"Kapadia, S. R. et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385, 2485\u20132491 (2015).","journal-title":"Lancet"},{"key":"570_CR28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011036","volume":"8","author":"G Delesalle","year":"2019","unstructured":"Delesalle, G. et al. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J. Am. Heart Assoc. 8, e011036 (2019).","journal-title":"J. Am. Heart Assoc."},{"issue":"Suppl. 1","key":"570_CR29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ccd.25863","volume":"85","author":"H Jilaihawi","year":"2015","unstructured":"Jilaihawi, H. et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter. Cardiovasc. Interv. 85 (Suppl. 1), 752\u2013761 (2015).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"570_CR30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.amjcard.2005.11.065","volume":"97","author":"E Barasch","year":"2006","unstructured":"Barasch, E. et al. Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). Am. J. Cardiol. 97, 1281\u20131286 (2006).","journal-title":"Am. J. Cardiol."},{"key":"570_CR31","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000155","volume":"1","author":"S Brecker","year":"2014","unstructured":"Brecker, S. et al. Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. Open Heart 1, e000155 (2014).","journal-title":"Open Heart"},{"key":"570_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/joim.12630","volume":"282","author":"SC Larsson","year":"2017","unstructured":"Larsson, S. C., Wolk, A. & B\u00e4ck, M. Alcohol consumption, cigarette smoking and incidence of aortic valve stenosis. J. Intern. Med. 282, 332\u2013339 (2017).","journal-title":"J. Intern. Med."},{"key":"570_CR33","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","volume":"69","author":"AT Yan","year":"2017","unstructured":"Yan, A. T. et al. Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. J. Am. Coll. Cardiol. 69, 1523\u20131532 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR34","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.4244\/EIJ-D-18-01010","volume":"14","author":"H Eggebrecht","year":"2019","unstructured":"Eggebrecht, H. & Mehta, R. H. Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly. EuroIntervention 14, e1549\u2013e1552 (2019).","journal-title":"EuroIntervention"},{"key":"570_CR35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(18)30473-2","volume":"391","author":"V Dziadzko","year":"2018","unstructured":"Dziadzko, V. et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet 391, 960\u2013969 (2018).","journal-title":"Lancet"},{"key":"570_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.114.012594","volume":"131","author":"FN Delling","year":"2015","unstructured":"Delling, F. N. et al. Familial clustering of mitral valve prolapse in the community. Circulation 131, 263\u2013268 (2015).","journal-title":"Circulation"},{"key":"570_CR37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/heartjnl-2014-307020","volume":"102","author":"S Coffey","year":"2016","unstructured":"Coffey, S., Cairns, B. J. & Iung, B. The modern epidemiology of heart valve disease. Heart 102, 75\u201385 (2016).","journal-title":"Heart"},{"key":"570_CR38","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/eurheartj\/ehz314","volume":"40","author":"V Dziadzko","year":"2019","unstructured":"Dziadzko, V. et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur. Heart J. 40, 2194\u20132202 (2019).","journal-title":"Eur. Heart J."},{"key":"570_CR39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","volume":"97","author":"A Rossi","year":"2011","unstructured":"Rossi, A. et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure: a quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97, 1675\u20131680 (2011).","journal-title":"Heart"},{"key":"570_CR40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016086","volume":"9","author":"D Messika-Zeitoun","year":"2020","unstructured":"Messika-Zeitoun, D. et al. Dismal outcomes and high societal burden of mitral valve regurgitation in France in the recent era: a nationwide perspective. J. Am. Heart Assoc. 9, e016086 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"570_CR41","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","volume":"103","author":"P Andell","year":"2017","unstructured":"Andell, P. et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart 103, 1696\u20131703 (2017).","journal-title":"Heart"},{"key":"570_CR42","volume":"10","author":"WKF Kong","year":"2017","unstructured":"Kong, W. K. F. et al. Sex differences in phenotypes of bicuspid aortic valve and aortopathy: insights from a large multicenter, international registry. Circ. Cardiovasc. Imaging 10, e005155 (2017).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"570_CR43","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1007\/s00330-016-4590-1","volume":"27","author":"C Celeng","year":"2017","unstructured":"Celeng, C. et al. Aortic root dimensions are predominantly determined by genetic factors: a classical twin study. Eur. Radiol. 27, 2419\u20132425 (2017).","journal-title":"Eur. Radiol."},{"key":"570_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/2047487320931630","author":"G Canciello","year":"2020","unstructured":"Canciello, G. et al. Determinants of aortic root dilatation over time in patients with essential hypertension: the Campania Salute Network. Eur. J. Prev. Cardiol. https:\/\/doi.org\/10.1177\/2047487320931630 (2020).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"570_CR45","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ahj.2007.07.030","volume":"154","author":"ER Fox","year":"2007","unstructured":"Fox, E. R. et al. Epidemiology of pure valvular regurgitation in the large middle-aged African American cohort of the Atherosclerosis Risk in Communities study. Am. Heart J. 154, 1229\u20131234 (2007).","journal-title":"Am. Heart J."},{"key":"570_CR46","volume":"6","author":"C Shu","year":"2016","unstructured":"Shu, C. et al. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China. Sci. Rep. 6, 27253 (2016).","journal-title":"Sci. Rep."},{"key":"570_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcaa068","author":"L von Kappelgaard","year":"2020","unstructured":"von Kappelgaard, L. et al. Temporal trends and socioeconomic differences in the incidence of left-sided valvular heart disease in Denmark. Eur. Heart J. Qual. Care Clin. Outcomes https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa068 (2020).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"570_CR48","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1093\/eurheartj\/ehy352","volume":"39","author":"EA Prihadi","year":"2018","unstructured":"Prihadi, E. A. et al. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. Eur. Heart J. 39, 3574\u20133581 (2018).","journal-title":"Eur. Heart J."},{"key":"570_CR49","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/eurheartj\/ehy608","volume":"39","author":"TF L\u00fcscher","year":"2018","unstructured":"L\u00fcscher, T. F. Valvular heart disease: tricuspid regurgitation is the new frontier. Eur. Heart J. 39, 3555\u20133557 (2018).","journal-title":"Eur. Heart J."},{"key":"570_CR50","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1093\/eurheartj\/ehy434","volume":"39","author":"Y Topilsky","year":"2018","unstructured":"Topilsky, Y. et al. Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. Eur. Heart J. 39, 3584\u20133592 (2018).","journal-title":"Eur. Heart J."},{"key":"570_CR51","first-page":"157","volume":"21","author":"E Chorin","year":"2020","unstructured":"Chorin, E. et al. Tricuspid regurgitation and long-term clinical outcomes. Eur. Heart J. Cardiovasc. Imaging 21, 157\u2013165 (2020).","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"570_CR52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","volume":"12","author":"Y Topilsky","year":"2019","unstructured":"Topilsky, Y. et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc. Imaging 12, 433\u2013442 (2019).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"570_CR53","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.jacc.2019.09.028","volume":"74","author":"M Taramasso","year":"2019","unstructured":"Taramasso, M. et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J. Am. Coll. Cardiol. 74, 2998\u20133008 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.amjcard.2020.11.024","volume":"140","author":"M Shariff","year":"2020","unstructured":"Shariff, M. et al. Ten years mortality trends of tricuspid regurgitation in the United States, 2008 to 2018. Am. J. Cardiol. 140, 156\u2013157 (2020).","journal-title":"Am. J. Cardiol."},{"key":"570_CR55","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.amjcard.2020.03.033","volume":"125","author":"D Kolte","year":"2020","unstructured":"Kolte, D. et al. Temporal trends in prevalence of tricuspid valve disease in hospitalized patients in the United States. Am. J. Cardiol. 125, 1879\u20131883 (2020).","journal-title":"Am. J. Cardiol."},{"key":"570_CR56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/icvts\/ivy127","volume":"27","author":"J Bustamante-Munguira","year":"2018","unstructured":"Bustamante-Munguira, J. et al. Surgery for acute infective endocarditis: epidemiological data from a Spanish nationwide hospital-based registry. Interact. Cardiovasc. Thorac. Surg. 27, 498\u2013504 (2018).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"570_CR57","volume":"96","author":"P-E Fournier","year":"2017","unstructured":"Fournier, P.-E. et al. Blood culture-negative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine 96, e8392 (2017).","journal-title":"Medicine"},{"key":"570_CR58","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/heartjnl-2019-315204","volume":"106","author":"H Hurrell","year":"2020","unstructured":"Hurrell, H., Roberts-Thomson, R. & Prendergast, B. D. Non-infective endocarditis. Heart 106, 1023\u20131029 (2020).","journal-title":"Heart"},{"key":"570_CR59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.gheart.2014.01.002","volume":"9","author":"AA Bin Abdulhak","year":"2014","unstructured":"Bin Abdulhak, A. A. et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob. Heart 9, 131\u2013143 (2014).","journal-title":"Glob. Heart"},{"key":"570_CR60","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","volume":"40","author":"G Habib","year":"2019","unstructured":"Habib, G. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry: a prospective cohort study. Eur. Heart J. 40, 3222\u20133232 (2019).","journal-title":"Eur. Heart J."},{"key":"570_CR61","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(20)30530-4","volume":"395","author":"MH Thornhill","year":"2020","unstructured":"Thornhill, M. H. et al. An alarming rise in incidence of infective endocarditis in England since 2009: why? Lancet 395, 1325\u20131327 (2020).","journal-title":"Lancet"},{"key":"570_CR62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11908-012-0265-5","volume":"14","author":"HS Yew","year":"2012","unstructured":"Yew, H. S. & Murdoch, D. R. Global trends in infective endocarditis epidemiology. Curr. Infect. Dis. Rep. 14, 367\u2013372 (2012).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"570_CR63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10654-020-00653-0","volume":"35","author":"L Zhao","year":"2020","unstructured":"Zhao, L. et al. Birth prevalence of congenital heart disease in China, 1980\u20132019: a systematic review and meta-analysis of 617 studies. Eur. J. Epidemiol. 35, 631\u2013642 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"570_CR64","first-page":"e139","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani, S. S. et al. Heart disease and stroke statistics \u2014 2020 update: a report from the American Heart Association. Circulation 141, e139\u2013e596 (2020).","journal-title":"Circulation"},{"key":"570_CR65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ije\/dyz009","volume":"48","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int. J. Epidemiol. 48, 455\u2013463 (2019).","journal-title":"Int. J. Epidemiol."},{"key":"570_CR66","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","volume":"58","author":"D van der Linde","year":"2011","unstructured":"van der Linde, D. et al. Birth prevalence of congenital heart disease worldwide. J. Am. Coll. Cardiol. 58, 2241\u20132247 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.amjcard.2003.11.031","volume":"93","author":"C Basso","year":"2004","unstructured":"Basso, C. et al. An echocardiographic survey of primary school children for bicuspid aortic valve. Am. J. Cardiol. 93, 661\u2013663 (2004).","journal-title":"Am. J. Cardiol."},{"key":"570_CR68","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjcard.2005.04.051","volume":"96","author":"S Nistri","year":"2005","unstructured":"Nistri, S. et al. Frequency of bicuspid aortic valve in young male conscripts by echocardiogram. Am. J. Cardiol. 96, 718\u2013721 (2005).","journal-title":"Am. J. Cardiol."},{"key":"570_CR69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ahj.2004.10.036","volume":"150","author":"E Tutar","year":"2005","unstructured":"Tutar, E. et al. The prevalence of bicuspid aortic valve in newborns by echocardiographic screening. Am. Heart J. 150, 513\u2013515 (2005).","journal-title":"Am. Heart J."},{"key":"570_CR70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.amjcard.2017.04.025","volume":"120","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Prevalence and complications of bicuspid aortic valve in Chinese according to echocardiographic database. Am. J. Cardiol. 120, 287\u2013291 (2017).","journal-title":"Am. J. Cardiol."},{"key":"570_CR71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.hlc.2006.06.001","volume":"15","author":"M-R Movahed","year":"2006","unstructured":"Movahed, M.-R., Hepner, A. D. & Ahmadi-Kashani, M. Echocardiographic prevalence of bicuspid aortic valve in the population. Heart Lung Circ. 15, 297\u2013299 (2006).","journal-title":"Heart Lung Circ."},{"key":"570_CR72","first-page":"603","volume":"105","author":"L Galian-Gay","year":"2019","unstructured":"Galian-Gay, L. et al. Familial clustering of bicuspid aortic valve and its relationship with aortic dilation in first-degree relatives. Heart 105, 603\u2013608 (2019).","journal-title":"Heart"},{"key":"570_CR73","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/2150135117706340","volume":"8","author":"F Edwin","year":"2017","unstructured":"Edwin, F. et al. Status and challenges of care in Africa for adults with congenital heart defects. World J. Pediatr. Congenit. Heart Surg. 8, 495\u2013501 (2017).","journal-title":"World J. Pediatr. Congenit. Heart Surg."},{"key":"570_CR74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2352-4642(19)30402-X","volume":"4","author":"MS Zimmerman","year":"2020","unstructured":"Zimmerman, M. S. et al. Global, regional, and national burden of congenital heart disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child. Adolesc. Health 4, 185\u2013200 (2020).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"570_CR75","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.110.946343","volume":"122","author":"P Moons","year":"2010","unstructured":"Moons, P. et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation 122, 2264\u20132272 (2010).","journal-title":"Circulation"},{"key":"570_CR76","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/eurheartj\/ehy668","volume":"40","author":"BD Prendergast","year":"2019","unstructured":"Prendergast, B. D. et al. Transcatheter heart valve interventions: where are we? Where are we going? Eur. Heart J. 40, 422\u2013440 (2019).","journal-title":"Eur. Heart J."},{"key":"570_CR77","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","volume":"140","author":"B Iung","year":"2019","unstructured":"Iung, B. et al. Contemporary presentation and management of valvular heart disease. Circulation 140, 1156\u20131169 (2019).","journal-title":"Circulation"},{"key":"570_CR78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamainternmed.2016.6936","volume":"177","author":"GL Hickey","year":"2017","unstructured":"Hickey, G. L. et al. National registry data and record linkage to inform postmarket surveillance of prosthetic aortic valve models over 15 years. JAMA Intern. Med. 177, 79\u201386 (2017).","journal-title":"JAMA Intern. Med."},{"key":"570_CR79","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jtcvs.2019.04.039","volume":"159","author":"D Vervoort","year":"2020","unstructured":"Vervoort, D. et al. Global cardiac surgery: access to cardiac surgical care around the world. J. Thorac. Cardiovasc. Surg. 159, 987\u2013996.e6 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"570_CR80","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/eurheartj\/ehy228","volume":"39","author":"T Pilgrim","year":"2018","unstructured":"Pilgrim, T. & Windecker, S. Expansion of transcatheter aortic valve implantation: new indications and socio-economic considerations. Eur. Heart J. 39, 2643\u20132645 (2018).","journal-title":"Eur. Heart J."},{"key":"570_CR81","first-page":"86","volume":"22","author":"D Garver","year":"1995","unstructured":"Garver, D. et al. The epidemiology of prosthetic heart valves in the United States. Tex. Heart Inst. J. 22, 86\u201391 (1995).","journal-title":"Tex. Heart Inst. J."},{"key":"570_CR82","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.athoracsur.2018.03.086","volume":"106","author":"JS Gammie","year":"2018","unstructured":"Gammie, J. S. et al. Isolated mitral valve surgery: the Society of Thoracic Surgeons adult cardiac surgery database analysis. Ann. Thorac. Surg. 106, 716\u2013727 (2018).","journal-title":"Ann. Thorac. Surg."},{"key":"570_CR83","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.athoracsur.2017.10.057","volume":"105","author":"SD Culler","year":"2018","unstructured":"Culler, S. D. et al. Trends in aortic valve replacement procedures between 2009 and 2015: has transcatheter aortic valve replacement made a difference? Ann. Thorac. Surg. 105, 1137\u20131143 (2018).","journal-title":"Ann. Thorac. Surg."},{"key":"570_CR84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jocs.13740","volume":"33","author":"KM Kim","year":"2018","unstructured":"Kim, K. M. et al. Evolving trends in aortic valve replacement: a statewide experience. J. Card. Surg. 33, 424\u2013430 (2018).","journal-title":"J. Card. Surg."},{"key":"570_CR85","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","volume":"76","author":"JD Carroll","year":"2020","unstructured":"Carroll, J. D. et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 76, 2492\u20132516 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"570_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2019.12.097","author":"S Zhou","year":"2020","unstructured":"Zhou, S. et al. Trends in MitraClip, mitral valve repair, and mitral valve replacement from 2000 to 2016. J. Thorac. Cardiovasc. Surg. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.12.097 (2020).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"570_CR87","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone, G. W. et al. Transcatheter mitral-valve repair in patients with heart failure. N. Engl. J. Med. 379, 2307\u20132318 (2018).","journal-title":"N. Engl. J. Med."},{"key":"570_CR88","volume":"8","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Effects of the angiotensin-receptor neprilysin inhibitor on cardiac reverse remodeling: meta-analysis. J. Am. Heart Assoc. 8, e012272 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"570_CR89","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(19)32600-5","volume":"394","author":"G Nickenig","year":"2019","unstructured":"Nickenig, G. et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet 394, 2002\u20132011 (2019).","journal-title":"Lancet"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00570-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T09:08:01Z","timestamp":1636708081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00570-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1038\/s41569-021-00570-z","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"17 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}